The goal of the cross-disciplinary international Hybrid Technology Hub is to develop an open source “organ on a chip” platform that reproduces core functionalities of the human body and allows real time data acquisition upon exposure to therapeutic reagents. A current focus is on energy metabolism regulating organs.
- New article and cover page in CellR4, the official journal of The Cure Alliance from the Scholz group Sep. 12, 2018
- Milestone in development of 3D Bioprinting of biomimetic pancreas to treat diabetes June 13, 2018
- Hybrid Technology Hub members recieve award from The Olav Thon Foundation Mar. 15, 2018